Financhill
Buy
67

XCNY Quote, Financials, Valuation and Earnings

Last price:
$24.49
Seasonality move :
--
Day range:
$25.19 - $25.20
52-week range:
$21.02 - $26.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
72
Avg. volume:
3K
1-year change:
--
Market cap:
--
Revenue:
--
EPS (TTM):
--

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, SPDR S&P Emerging Markets ex-China ETF has -- downside to fair value with a price target of -- per share.

XCNY vs. S&P 500

  • Over the past 5 trading days, SPDR S&P Emerging Markets ex-China ETF has underperformed the S&P 500 by -0.94% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • SPDR S&P Emerging Markets ex-China ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • SPDR S&P Emerging Markets ex-China ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SPDR S&P Emerging Markets ex-China ETF reported revenues of --.

Earnings Growth

  • SPDR S&P Emerging Markets ex-China ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SPDR S&P Emerging Markets ex-China ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
Trailing 12 Months Fiscal Quarters
Period Ending 2023-05-15 2024-05-15 2024-05-15
Income Statement
Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
Operating Income -- -- -- -- --
EBITDA -- -- -- -- --
Diluted EPS -- -- -- -- --
Period Ending 2021-05-15 2022-05-15 2023-05-15 2024-05-15
Balance Sheet
Current Assets -- -- -- -- --
Total Assets -- -- -- -- --
Current Liabilities -- -- -- -- --
Total Liabilities -- -- -- -- --
Total Equity -- -- -- -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2023-05-15 2024-05-15 2024-05-15
Cash Flow Statement
Cash Flow Operations -- -- -- -- --
Cash From Investing -- -- -- -- --
Cash From Financing -- -- -- -- --
Free Cash Flow -- -- -- -- --
XCNY
Sector
Market Cap
--
--
Price % of 52-Week High
94.69%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
--
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $24.66
200-day SMA
Buy
Level $0.00
Bollinger Bands (100)
Buy
Level 22.98 - 24.34
Chaikin Money Flow
Sell
Level -30.2K
20-day SMA
Buy
Level $23.96
Relative Strength Index (RSI14)
Buy
Level 68.81
ADX Line
Buy
Level 24.81
Williams %R
Sell
Level 0
50-day SMA
Buy
Level $23.43
MACD (12, 26)
Buy
Level 0.50
25-day Aroon Oscillator
Buy
Level 96
On Balance Volume
Neutral
Level 104.1K

Financial Scores

--
Altman Z-Score (Annual)
Level (--)
--
CA Score (Annual)
Level (--)
--
Beneish M-Score (Annual)
Level (--)
--
Momentum Score
Level (--)
--
Ohlson Score
Level (--)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)

Revenue Forecast

Earnings per Share Forecast

Stock Forecast FAQ

In the current month, XCNY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The XCNY average analyst price target in the past 3 months is --.

  • Where Will SPDR S&P Emerging Markets ex-China ETF Stock Be In 1 Year?

    According to analysts, the consensus estimate is that SPDR S&P Emerging Markets ex-China ETF share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About SPDR S&P Emerging Markets ex-China ETF?

    Analysts are divided on their view about SPDR S&P Emerging Markets ex-China ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SPDR S&P Emerging Markets ex-China ETF is a Sell and believe this share price will rise from its current level to --.

  • What Is SPDR S&P Emerging Markets ex-China ETF's Price Target?

    The price target for SPDR S&P Emerging Markets ex-China ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is XCNY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for SPDR S&P Emerging Markets ex-China ETF is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of XCNY?

    You can purchase shares of SPDR S&P Emerging Markets ex-China ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SPDR S&P Emerging Markets ex-China ETF shares.

  • What Is The SPDR S&P Emerging Markets ex-China ETF Share Price Today?

    SPDR S&P Emerging Markets ex-China ETF was last trading at $24.49 per share. This represents the most recent stock quote for SPDR S&P Emerging Markets ex-China ETF. Yesterday, SPDR S&P Emerging Markets ex-China ETF closed at $25.20 per share.

  • How To Buy SPDR S&P Emerging Markets ex-China ETF Stock Online?

    In order to purchase SPDR S&P Emerging Markets ex-China ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
RGC alert for May 15

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 26.31% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 20.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock